Even if the liquid biopsy presents various patient benefits, it is not yet implemented in current clinical practice, but this aspect may be a matter of time, due to the fact that PSA testing is also a blood-based test that is already a golden standard in the diagnosis of PCa patients. Here, KLK3 is linked to posterior cortical atrophy.